How did AVAH's revenue and expenses shift in Q4 2024 compared to previous quarters?

Aveanna Healthcare Holdings Inc. (AVAH) exhibited notable improvements in revenue and financial performance in Q4 2024, compared to previous quarters, as evidenced by the following key points:

1. **Revenue Increase**: AVAH's revenue in Q4 2024 was $519.87 million, reflecting an 8.6% increase over the prior year period. This growth was driven by strong revenues from the Private Duty Services and Medical Solutions segments.

2. **Gross Margin Improvement**: The company's gross margin increased by 15.7% to $171.7 million compared to Q4 2023. This improvement indicates enhanced operational efficiency and profitability.
3. **Net Income Turnaround**: AVAH achieved a net income of $29.2 million in Q4 2024, a significant turnaround from a net loss of $25.7 million in the comparable prior year period. This demonstrates effective cost management and operational improvements.
4. **Adjusted EBITDA Growth**: The adjusted EBITDA for Q4 2024 was $55.2 million, marking a 42.8% increase over the prior year period. This indicates robust cash flow generation and a strong financial performance.
5. **Expense Insights**: There are no available data on AVAH's expenses in Q4 2024. However, the company's financial results and outlook reports suggest that AVAH has been successful in managing costs, as evidenced by the significant increase in gross margin and net income.

In summary, AVAH's revenue and expenses in Q4 2024 showed substantial improvements compared to previous quarters, driven by strong revenue growth, enhanced gross margin, and effective cost management.